(firstQuint)Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation.

 This study will be a phase III open label interventional case series.

 Patients with Stage I enucleated retinoblastoma will be randomized to receive chemotherapy(CEV) of 3 cycles or 6 cycles on a monthly basis.

 Patients will be followed for 24 months.

.

 Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation@highlight

The purpose of this study is to determine whether 3 cycles of chemotherapy(CEV) are as effective as 6 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.

